DA32 Life Science Tech Acquisition Corp. announced the pricing of its $200 million IPO and its shares are expected to begin trading on the Nasdaq under the symbol “DALS” Wednesday, July 28.
The new SPAC, sponsored by affiliates of Deerfield Management Company, L.P. (“Deerfield”), ARCH Venture Partners (“ARCH”) and Section 32, aims to combine with a target that addresses unmet research, clinical or commercial needs in a large and growing addressable market. DA32 Life Science Tech is led by CEO Steve Kafka and CFO and Secretary Christopher Wolfe.
Total SPAC deal count for 2021 year-to-date is now 383. This offering is expected to close on Friday, July 30.
J.P. Morgan Securities LLC and Cowen and Company, LLC are serving as joint bookrunning managers of the offering. White & Case LLP is serving as Issuer’s Counsel with Kirkland & Ellis LLP serving as Underwriter’s Counsel. WithumSmith+Brown, PC serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn Although the market has largely recovered from a negative stretch last week, the roller coaster is tilted back downward for Trump Media (NASDAQ:DJT), which slid -8% yesterday to $32.57 – one of its lowest points since closing with Digital World last month. Other SPACs and de-SPACs are having a more...
Remember the metaverse? Many do not. Meta’s (NASDAQ:META) attempted transition to virtually living and working seemed to mark a trend that went up and down quickly, but one SPAC deal has both survived that roller coaster and may rise with a second. Back in December 2022, Newbury Street (NASDAQ:NBST) announced a $1.85 billion combination with...
At the SPAC of Dawn Tucked into the bill that provides $95 billion in funding to American allies passed by the House this weekend is another measure that is likely to have far more impact on at least one pending deal in SPAC world. It would appear that the timing was fortuitous for TikTok rival...
With the passage this weekend of $95 billion in funding for Ukraine, Israel and Taiwan by the House of Representatives, some focus has gone back towards the defense sector, which has generally had a good year as a whole. But, SPACs have not been as active in defense, despite the fact that companies in the...
At the SPAC of Dawn As April’s sleepy month for SPAC news continues, there is only one special meeting on the docket to consider a SPAC deal approval, that being today’s vote on Pegasus Digital Mobility‘s (NYSE:PGSS) combination with equipment manufacturer Schmid. Three more SPACs are facing extension votes this week, including Pyrophyte (NYSE:PHYT), whose...